Quantitative Analysis of Conjunctival and Retinal Vessels in Fabry Disease.
Journal
Journal of ophthalmology
ISSN: 2090-004X
Titre abrégé: J Ophthalmol
Pays: United States
ID NLM: 101524199
Informations de publication
Date de publication:
2019
2019
Historique:
received:
01
11
2018
revised:
11
02
2019
accepted:
19
03
2019
entrez:
17
5
2019
pubmed:
17
5
2019
medline:
17
5
2019
Statut:
epublish
Résumé
Fabry Disease (FD) is a rare X-linked lysosomal storage disorder characterized by systemic and ocular involvement. It has been described an increasing in retinal and conjunctival vessel tortuosity and this feature represents an important marker for the disease. Currently, there is not an objective method to measure and quantify this parameter. We tested a new semi-automatic software measuring retinal and conjunctival vessel tortuosity from eye fundus and conjunctival digital images in a group of FD patients. We performed an observational case-control study evaluating three mathematical parameters describing tortuosity (sum of angle metric [SOAM], product of angle distance [PAD], triangular index [I2e]) obtained from fundus and conjunctival pictures of 11 FD patients and 11 age and sex-matched controls. Both eyes were considered. Mann-Whitney test was used to compare the FD group versus the control group and, within the FD group, male versus female patients. Linear regression analysis was performed to evaluate the possible association of retinal and conjunctival vessels tortuosity parameters with age and with specific markers of systemic disease's progression. The tortuosity parameters (SOAM, PAD and I2e) were significantly higher in retinal vessels and in conjunctival nasal vessels in FD patients in comparison with the controls (
Identifiants
pubmed: 31093369
doi: 10.1155/2019/4696429
pmc: PMC6481025
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4696429Références
Arch Ophthalmol. 1979 Apr;97(4):671-6
pubmed: 106811
J Inherit Metab Dis. 2001;24 Suppl 2:71-4; discussion 65
pubmed: 11758682
Medicine (Baltimore). 2002 Mar;81(2):122-38
pubmed: 11889412
J Soc Biol. 2002;196(2):161-73
pubmed: 12360745
Ann Intern Med. 2003 Feb 18;138(4):338-46
pubmed: 12585833
Ophthalmic Genet. 2003 Sep;24(3):129-39
pubmed: 12868031
Eur J Clin Invest. 2004 Mar;34(3):236-42
pubmed: 15025684
Clin Genet. 2004 Apr;65(4):299-307
pubmed: 15025723
J Intern Med. 2004 Jun;255(6):629-36
pubmed: 15147526
Joint Bone Spine. 2004 Sep;71(5):381-3
pubmed: 15474388
J Fr Ophtalmol. 2005 Jan;28(1):45-50
pubmed: 15767898
Clin Exp Ophthalmol. 2005 Apr;33(2):164-8
pubmed: 15807825
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4734-8
pubmed: 16303973
Hum Genomics. 2006 Mar;2(5):297-309
pubmed: 16595074
Clin Exp Ophthalmol. 2006 Jul;34(5):397-400
pubmed: 16872333
Br J Ophthalmol. 2007 Feb;91(2):210-4
pubmed: 16973664
Ann Intern Med. 2007 Mar 20;146(6):425-33
pubmed: 17371887
Arch Ophthalmol. 2007 Nov;125(11):1523-30
pubmed: 17998514
Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3577-85
pubmed: 18408177
Acta Ophthalmol. 2009 Jun;87(4):368-77
pubmed: 19210329
Genet Med. 2010 Nov;12(11):668-79
pubmed: 20962662
Orphanet J Rare Dis. 2010 Nov 22;5:30
pubmed: 21092187
Ophthalmologica. 1978;176(6):313-30
pubmed: 211468
Acta Ophthalmol. 2013 Mar;91(2):e113-9
pubmed: 23164241
Brain Dev. 2013 Jun;35(6):515-23
pubmed: 23290321
Mol Genet Metab. 2014 Apr;111(4):499-506
pubmed: 24534763
Graefes Arch Clin Exp Ophthalmol. 1986;224(5):477-80
pubmed: 3758696
Am J Ophthalmol. 1972 Mar;73(3):419-30
pubmed: 4335185
Arch Ophthalmol. 1965 Dec;74(6):760-9
pubmed: 5846554
J Fr Ophtalmol. 1980;3(11):625-30
pubmed: 6259247
JAMA. 1999 Jan 20;281(3):249-54
pubmed: 9918480